{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T21:15:45Z","timestamp":1779138945097,"version":"3.51.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"published-print":{"date-parts":[[2007,11,1]]},"DOI":"10.1038\/sj.embor.7401090","type":"journal-article","created":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T06:10:55Z","timestamp":1193897455000},"page":"1024-1030","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Non\u2010classical major histocompatibility complex proteins as determinants of tumour immunosurveillance"],"prefix":"10.1038","volume":"8","author":[{"given":"Anita Q.","family":"Gomes","sequence":"first","affiliation":[]},{"given":"Daniel V.","family":"Correia","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Silva\u2010Santos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,11,1]]},"reference":[{"key":"BFEMBR7401090_CR1","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.4049\/jimmunol.176.3.1331","volume":"176","author":"R Bahri","year":"2006","unstructured":"Bahri R, Hirsch F, Josse A, Rouas\u2010Freiss N, Bidere N, Vasquez A, Carosella ED, Charpentier B, Durrbach A (2006) Soluble HLA\u2010G inhibits cell cycle progression in human alloreactive T lymphocytes. J Immunol 176: 1331\u20131339","journal-title":"J Immunol"},{"key":"BFEMBR7401090_CR2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","volume":"285","author":"S Bauer","year":"1999","unstructured":"Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress\u2010inducible MICA. Science 285: 727\u2013729","journal-title":"Science"},{"key":"BFEMBR7401090_CR3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.4049\/jimmunol.177.2.769","volume":"177","author":"RR Brutkiewicz","year":"2006","unstructured":"Brutkiewicz RR (2006) CD1d ligands: the good, the bad, and the ugly. J Immunol 177: 769\u2013775","journal-title":"J Immunol"},{"key":"BFEMBR7401090_CR4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.4049\/jimmunol.176.2.905","volume":"176","author":"JD Bui","year":"2006","unstructured":"Bui JD, Carayannopoulos LN, Lanier LL, Yokoyama WM, Schreiber RD (2006) IFN\u2010dependent down\u2010regulation of the NKG2D ligand H60 on tumours. J Immunol 176: 905\u2013913","journal-title":"J Immunol"},{"key":"BFEMBR7401090_CR5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.1.5023.841","volume":"1","author":"M Burnet","year":"1957","unstructured":"Burnet M (1957) Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications. Br Med J 1: 841\u2013847","journal-title":"Br Med J"},{"key":"BFEMBR7401090_CR6","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.4049\/jimmunol.169.8.4079","volume":"169","author":"LN Carayannopoulos","year":"2002","unstructured":"Carayannopoulos LN, Naidenko OV, Fremont DH, Yokoyama WM (2002) Cutting edge: murine UL16\u2010binding protein\u2010like transcript 1: a newly described transcript encoding a high\u2010affinity ligand for murine NKG2D. J Immunol 169: 4079\u20134083","journal-title":"J Immunol"},{"key":"BFEMBR7401090_CR7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1044-579X(03)00021-X","volume":"13","author":"ED Carosella","year":"2003","unstructured":"Carosella ED, Dausset J (2003) Progress of HLA\u2010G in cancer. Semin Cancer Biol 13: 315\u2013316","journal-title":"Semin Cancer Biol"},{"key":"BFEMBR7401090_CR8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0065-2776(03)81006-4","volume":"81","author":"ED Carosella","year":"2003","unstructured":"Carosella ED, Moreau P, Le Maoult J, Le Discorde M, Dausset J, Rouas\u2010Freiss N (2003) HLA\u2010G molecules: from maternal\u2013fetal tolerance to tissue acceptance. Adv Immunol 81: 199\u2013252","journal-title":"Adv Immunol"},{"key":"BFEMBR7401090_CR9","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.emboj.7601570","volume":"26","author":"J Caumartin","year":"2007","unstructured":"Caumartin J, Favier B, Daouya M, Guillard C, Moreau P, Carosella ED, LeMaoult J (2007) Trogocytosis\u2010based generation of suppressive NK cells. EMBO J 26: 1423\u20131433","journal-title":"EMBO J"},{"key":"BFEMBR7401090_CR10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1074-7613(00)80222-8","volume":"12","author":"A Cerwenka","year":"2000","unstructured":"Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, Lanier LL (2000) Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12: 721\u2013727","journal-title":"Immunity"},{"key":"BFEMBR7401090_CR11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.humimm.2003.08.357","volume":"64","author":"CC Chang","year":"2003","unstructured":"Chang CC, Murphy SP, Ferrone S (2003) Differential in vivo and in vitro HLA\u2010G expression in melanoma cells: potential mechanisms. Hum Immunol 64: 1057\u20131063","journal-title":"Hum Immunol"},{"key":"BFEMBR7401090_CR12","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.4049\/jimmunol.173.7.4394","volume":"173","author":"EY Chiang","year":"2004","unstructured":"Chiang EY, Stroynowski I (2004) A nonclassical MHC class I molecule restricts CTL\u2010mediated rejection of a syngeneic melanoma tumour. J Immunol 173: 4394\u20134401","journal-title":"J Immunol"},{"key":"BFEMBR7401090_CR13","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.4049\/jimmunol.174.9.5367","volume":"174","author":"EY Chiang","year":"2005","unstructured":"Chiang EY, Stroynowski I (2005) Protective immunity against disparate tumours is mediated by a nonpolymorphic MHC class I molecule. J Immunol 174: 5367\u20135374","journal-title":"J Immunol"},{"key":"BFEMBR7401090_CR14","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.4049\/jimmunol.177.4.2123","volume":"177","author":"EY Chiang","year":"2006","unstructured":"Chiang EY, Stroynowski I (2006) The role of structurally conserved class I MHC in tumour rejection: contribution of the Q8 locus. J Immunol 177: 2123\u20132130","journal-title":"J Immunol"},{"key":"BFEMBR7401090_CR15","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.4049\/jimmunol.170.9.4515","volume":"170","author":"EY Chiang","year":"2003","unstructured":"Chiang EY, Henson M, Stroynowski I (2003) Correction of defects responsible for impaired Qa\u20102 class Ib MHC expression on melanoma cells protects mice from tumour growth. J Immunol 170: 4515\u20134523","journal-title":"J Immunol"},{"key":"BFEMBR7401090_CR16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.humimm.2003.08.352","volume":"64","author":"M Comiskey","year":"2003","unstructured":"Comiskey M, Goldstein CY, De Fazio SR, Mammolenti M, Newmark JA, Warner CM (2003) Evidence that HLA\u2010G is the functional homolog of mouse Qa\u20102, the Ped gene product. Hum Immunol 64: 999\u20131004","journal-title":"Hum Immunol"},{"key":"BFEMBR7401090_CR17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1074-7613(01)00095-4","volume":"14","author":"D Cosman","year":"2001","unstructured":"Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, Kubin M, Chalupny NJ (2001) ULBPs, novel MHC class I\u2010related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14: 123\u2013133","journal-title":"Immunity"},{"key":"BFEMBR7401090_CR18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1084\/jem.20020092","volume":"196","author":"NY Crowe","year":"2002","unstructured":"Crowe NY, Smyth MJ, Godfrey DI (2002) A critical role for natural killer T cells in immunosurveillance of methylcholanthrene\u2010induced sarcomas. J Exp Med 196: 119\u2013127","journal-title":"J Exp Med"},{"key":"BFEMBR7401090_CR19","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.20050953","volume":"202","author":"NY Crowe","year":"2005","unstructured":"Crowe NY, Coquet JM, Berzins SP, Kyparissoudis K, Keating R, Pellicci DG, Hayakawa Y, Godfrey DI, Smyth MJ (2005) Differential antitumour immunity mediated by NKT cell subsets in vivo. J Exp Med 202: 1279\u20131288","journal-title":"J Exp Med"},{"key":"BFEMBR7401090_CR20","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1084\/jem.20031030","volume":"198","author":"MV Dhodapkar","year":"2003","unstructured":"Dhodapkar MV, Krasovsky J, Osman K, Geller MD (2003) Vigorous premalignancy\u2010specific effector T cell response in the bone marrow of patients with monoclonal gammopathy. J Exp Med 198: 1753\u20131757","journal-title":"J Exp Med"},{"key":"BFEMBR7401090_CR21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/77793","volume":"1","author":"A Diefenbach","year":"2000","unstructured":"Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH (2000) Ligands for the murine NKG2D receptor: expression by tumour cells and activation of NK cells and macrophages. Nat Immunol 1: 119\u2013126","journal-title":"Nat Immunol"},{"key":"BFEMBR7401090_CR22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35093109","volume":"413","author":"A Diefenbach","year":"2001","unstructured":"Diefenbach A, Jensen ER, Jamieson AM, Raulet DH (2001) Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413: 165\u2013171","journal-title":"Nature"},{"key":"BFEMBR7401090_CR23","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","volume":"3","author":"GP Dunn","year":"2002","unstructured":"Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD (2002) Cancer immunoediting: from immunosurveillance to tumour escape. Nat Immunol 3: 991\u2013998","journal-title":"Nat Immunol"},{"key":"BFEMBR7401090_CR24","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ni827","volume":"3","author":"S Fujii","year":"2002","unstructured":"Fujii S, Shimizu K, Kronenberg M, Steinman RM (2002) Prolonged IFN\u2010\u03b3\u2010producing NKT response induced with \u03b1\u2010galactosylceramide\u2010loaded DCs. Nat Immunol 3: 867\u2013874","journal-title":"Nat Immunol"},{"key":"BFEMBR7401090_CR25","first-page":"3702","volume":"8","author":"G Giaccone","year":"2002","unstructured":"Giaccone G et al (2002) A phase I study of the natural killer T\u2010cell ligand \u03b1\u2010galactosylceramide (KRN7000) in patients with solid tumours. Clin Cancer Res 8: 3702\u20133709","journal-title":"Clin Cancer Res"},{"key":"BFEMBR7401090_CR26","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1126\/science.1063916","volume":"294","author":"M Girardi","year":"2001","unstructured":"Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE, Hayday AC (2001) Regulation of cutaneous malignancy by \u03b3\u03b4 T cells. Science 294: 605\u2013609","journal-title":"Science"},{"key":"BFEMBR7401090_CR27","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20021282","volume":"198","author":"M Girardi","year":"2003","unstructured":"Girardi M, Glusac E, Filler RB, Roberts SJ, Propperova I, Lewis J, Tigelaar RE, Hayday AC (2003) The distinct contributions of murine T cell receptor (TCR)\u03b3\u03b4+ and TCR\u03b1\u03b2+ T cells to different stages of chemically induced skin cancer. J Exp Med 198: 747\u2013755","journal-title":"J Exp Med"},{"key":"BFEMBR7401090_CR28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1309","volume":"4","author":"DI Godfrey","year":"2004","unstructured":"Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L (2004) NKT cells: what's in a name? Nat Rev Immunol 4: 231\u2013237","journal-title":"Nat Rev Immunol"},{"key":"BFEMBR7401090_CR29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nature01112","volume":"419","author":"V Groh","year":"2002","unstructured":"Groh V, Wu J, Yee C, Spies T (2002) Tumour\u2010derived soluble MIC ligands impair expression of NKG2D and T\u2010cell activation. Nature 419: 734\u2013738","journal-title":"Nature"},{"key":"BFEMBR7401090_CR30","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.4049\/jimmunol.154.7.3283","volume":"154","author":"T Guillaudeux","year":"1995","unstructured":"Guillaudeux T, Rodriguez AM, Girr M, Mallet V, Ellis SA, Sargent IL, Fauchet R, Alsat E, Le Bouteiller P (1995) Methylation status and transcriptional expression of the MHC class I loci in human trophoblast cells from term placenta. J Immunol 154: 3283\u20133299","journal-title":"J Immunol"},{"key":"BFEMBR7401090_CR31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1074-7613(00)80174-0","volume":"12","author":"JE Gumperz","year":"2000","unstructured":"Gumperz JE, Roy C, Makowska A, Lum D, Sugita M, Podrebarac T, Koezuka Y, Porcelli SA, Cardell S, Brenner MB, Behar SM (2000) Murine CD1d\u2010restricted T cell recognition of cellular lipids. Immunity 12: 211\u2013221","journal-title":"Immunity"},{"key":"BFEMBR7401090_CR32","doi-asserted-by":"crossref","first-page":"9464","DOI":"10.1073\/pnas.1630663100","volume":"100","author":"Y Hayakawa","year":"2003","unstructured":"Hayakawa Y, Rovero S, Forni G, Smyth MJ (2003) \u03b1\u2010Galactosylceramide (KRN7000) suppression of chemical\u2010 and oncogene\u2010dependent carcinogenesis. Proc Natl Acad Sci USA 100: 9464\u20139469","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR7401090_CR33","first-page":"3081","volume":"42","author":"HM Hurks","year":"2001","unstructured":"Hurks HM, Valter MM, Wilson L, Hilgert I, van den Elsen PJ, Jager MJ (2001) Uveal melanoma: no expression of HLA\u2010G. Invest Ophthalmol Vis Sci 42: 3081\u20133084","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFEMBR7401090_CR34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1379\/1466-1268(2000)005<0207:HSAAIE>2.0.CO;2","volume":"5","author":"EC Ibrahim","year":"2000","unstructured":"Ibrahim EC, Morange M, Dausset J, Carosella ED, Paul P (2000) Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA\u2010G gene in tumour cell lines. Cell Stress Chaperones 5: 207\u2013218","journal-title":"Cell Stress Chaperones"},{"key":"BFEMBR7401090_CR35","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1158\/1078-0432.CCR-04-1453","volume":"11","author":"A Ishikawa","year":"2005","unstructured":"Ishikawa A, Motohashi S, Ishikawa E, Fuchida H, Higashino K, Otsuji M, Iizasa T, Nakayama T, Taniguchi M, Fujisawa T (2005) A phase I study of \u03b1\u2010galactosylceramide (KRN7000)\u2010pulsed dendritic cells in patients with advanced and recurrent non\u2010small cell lung cancer. Clin Cancer Res 11: 1910\u20131917","journal-title":"Clin Cancer Res"},{"key":"BFEMBR7401090_CR36","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1073\/pnas.95.10.5690","volume":"95","author":"T Kawano","year":"1998","unstructured":"Kawano T et al (1998) Natural killer\u2010like nonspecific tumour cell lysis mediated by specific ligand\u2010activated V\u03b114] NKT cells. Proc Natl Acad Sci USA 95: 5690\u20135693","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR7401090_CR37","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.4049\/jimmunol.171.7.3415","volume":"171","author":"A Kikuchi\u2010Maki","year":"2003","unstructured":"Kikuchi\u2010Maki A, Yusa S, Catina TL, Campbell KS (2003) KIR2DL4 is an IL\u20102\u2010regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN\u2010\u03b3 production. J Immunol 171: 3415\u20133425","journal-title":"J Immunol"},{"key":"BFEMBR7401090_CR38","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature03407","volume":"434","author":"Y Kinjo","year":"2005","unstructured":"Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong CH, Kronenberg M (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520\u2013525","journal-title":"Nature"},{"key":"BFEMBR7401090_CR39","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/1521-4141(200105)31:5<1428::AID-IMMU1428>3.0.CO;2-4","volume":"31","author":"M Kubin","year":"2001","unstructured":"Kubin M, Cassiano L, Chalupny J, Chin W, Cosman D, Fanslow W, Mullberg J, Rousseau AM, Ulrich D, Armitage R (2001) ULBP1, 2, 3: novel MHC class I\u2010related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. Eur J Immunol 31: 1428\u20131437","journal-title":"Eur J Immunol"},{"key":"BFEMBR7401090_CR40","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1073\/pnas.0401922101","volume":"101","author":"J LeMaoult","year":"2004","unstructured":"LeMaoult J, Krawice\u2010Radanne I, Dausset J, Carosella ED (2004) HLA\u2010G1\u2010expressing antigen\u2010presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci USA 101: 7064\u20137069","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR7401090_CR41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature03408","volume":"434","author":"J Mattner","year":"2005","unstructured":"Mattner J et al (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525\u2013529","journal-title":"Nature"},{"key":"BFEMBR7401090_CR42","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.1158\/0008-5472.CAN-06-4588","volume":"67","author":"F Morandi","year":"2007","unstructured":"Morandi F, Levreri I, Bocca P, Galleni B, Raffaghello L, Ferrone S, Prigione I, Pistoia V (2007) Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA\u2010G release. Cancer Res 67: 6433\u20136441","journal-title":"Cancer Res"},{"key":"BFEMBR7401090_CR43","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/ijc.20682","volume":"113","author":"G Mouillot","year":"2005","unstructured":"Mouillot G, Marcou C, Rousseau P, Rouas\u2010Freiss N, Carosella ED, Moreau P (2005) HLA\u2010G gene activation in tumour cells involves cis\u2010acting epigenetic changes. Int J Cancer 113: 928\u2013936","journal-title":"Int J Cancer"},{"key":"BFEMBR7401090_CR44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.humimm.2006.10.016","volume":"68","author":"G Mouillot","year":"2007","unstructured":"Mouillot G, Marcou C, Zidi I, Guillard C, Sangrouber D, Carosella ED, Moreau P (2007) Hypoxia modulates HLA\u2010G gene expression in tumour cells. Hum Immunol 68: 277\u2013285","journal-title":"Hum Immunol"},{"key":"BFEMBR7401090_CR45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood-2003-04-1155","volume":"103","author":"M Nieda","year":"2004","unstructured":"Nieda M, Okai M, Tazbirkova A, Lin H, Yamaura A, Ide K, Abraham R, Juji T, Macfarlane DJ, Nicol AJ (2004) Therapeutic activation of V\u03b124+V\u03b211+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 103: 383\u2013389","journal-title":"Blood"},{"key":"BFEMBR7401090_CR46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1074-7613(02)00505-8","volume":"18","author":"K Ogasawara","year":"2003","unstructured":"Ogasawara K, Hamerman JA, Hsin H, Chikuma S, Bour\u2010Jordan H, Chen T, Pertel T, Carnaud C, Bluestone JA, Lanier LL (2003) Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18: 41\u201351","journal-title":"Immunity"},{"key":"BFEMBR7401090_CR47","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ni1239","volume":"6","author":"DE Oppenheim","year":"2005","unstructured":"Oppenheim DE, Roberts SJ, Clarke SL, Filler R, Lewis JM, Tigelaar RE, Girardi M, Hayday AC (2005) Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumour immunosurveillance. Nat Immunol 6: 928\u2013937","journal-title":"Nat Immunol"},{"key":"BFEMBR7401090_CR48","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1073\/pnas.96.10.5674","volume":"96","author":"M Ponte","year":"1999","unstructured":"Ponte M, Cantoni C, Biassoni R, Tradori\u2010Cappai A, Bentivoglio G, Vitale C, Bertone S, Moretta A, Moretta L, Mingari MC (1999) Inhibitory receptors sensing HLA\u2010G1 molecules in pregnancy: decidua\u2010associated natural killer cells express LIR\u20101 and CD94\/NKG2A and acquire p49, an HLA\u2010G1\u2010specific receptor. Proc Natl Acad Sci USA 96: 5674\u20135679","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR7401090_CR49","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.4049\/jimmunol.167.4.1877","volume":"167","author":"S Rajagopalan","year":"2001","unstructured":"Rajagopalan S, Fu J, Long EO (2001) Cutting edge: induction of IFN\u2010\u03b3 production but not cytotoxicity by the killer cell Ig\u2010like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol 167: 1877\u20131881","journal-title":"J Immunol"},{"key":"BFEMBR7401090_CR50","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nri1199","volume":"3","author":"DH Raulet","year":"2003","unstructured":"Raulet DH (2003) Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3: 781\u2013790","journal-title":"Nat Rev Immunol"},{"key":"BFEMBR7401090_CR51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nri1635","volume":"5","author":"JR Rodgers","year":"2005","unstructured":"Rodgers JR, Cook RG (2005) MHC class Ib molecules bridge innate and acquired immunity. Nat Rev Immunol 5: 459\u2013471","journal-title":"Nat Rev Immunol"},{"key":"BFEMBR7401090_CR52","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1158\/0008-5472.CAN-05-0097","volume":"65","author":"N Rouas\u2010Freiss","year":"2005","unstructured":"Rouas\u2010Freiss N, Moreau P, Ferrone S, Carosella ED (2005) HLA\u2010G proteins in cancer: do they provide tumour cells with an escape mechanism? Cancer Res 65: 10139\u201310144","journal-title":"Cancer Res"},{"key":"BFEMBR7401090_CR53","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.4049\/jimmunol.169.8.4098","volume":"169","author":"HR Salih","year":"2002","unstructured":"Salih HR, Rammensee HG, Steinle A (2002) Cutting edge: down\u2010regulation of MICA on human tumours by proteolytic shedding. J Immunol 169: 4098\u20134102","journal-title":"J Immunol"},{"key":"BFEMBR7401090_CR54","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1471-4906(02)00039-X","volume":"24","author":"B Seliger","year":"2003","unstructured":"Seliger B, Abken H, Ferrone S (2003) HLA\u2010G and MIC expression in tumours and their role in anti\u2010tumour immunity. Trends Immunol 24: 82\u201387","journal-title":"Trends Immunol"},{"key":"BFEMBR7401090_CR55","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.191.4.661","volume":"191","author":"MJ Smyth","year":"2000","unstructured":"Smyth MJ, Thia KY, Street SE, Cretney E, Trapani JA, Taniguchi M, Kawano T, Pelikan SB, Crowe NY, Godfrey DI (2000) Differential tumour surveillance by natural killer (NK) and NKT cells. J Exp Med 191: 661\u2013668","journal-title":"J Exp Med"},{"key":"BFEMBR7401090_CR56","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/intimm\/13.4.459","volume":"13","author":"MJ Smyth","year":"2001","unstructured":"Smyth MJ, Crowe NY, Godfrey DI (2001) NK cells and NKT cells collaborate in host protection from methylcholanthrene\u2010induced fibrosarcoma. Int Immunol 13: 459\u2013463","journal-title":"Int Immunol"},{"key":"BFEMBR7401090_CR57","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood.V99.4.1259","volume":"99","author":"MJ Smyth","year":"2002","unstructured":"Smyth MJ, Crowe NY, Pellicci DG, Kyparissoudis K, Kelly JM, Takeda K, Yagita H, Godfrey DI (2002) Sequential production of interferon\u2010\u03b3 by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of \u03b1\u2010galactosylceramide. Blood 99: 1259\u20131266","journal-title":"Blood"},{"key":"BFEMBR7401090_CR58","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.1073\/pnas.122636199","volume":"99","author":"V Sriram","year":"2002","unstructured":"Sriram V, Cho S, Li P, O'Donnell PW, Dunn C, Hayakawa K, Blum JS, Brutkiewicz RR (2002) Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cells. Proc Natl Acad Sci USA 99: 8197\u20138202","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR7401090_CR59","doi-asserted-by":"crossref","first-page":"R282","DOI":"10.1016\/S0960-9822(00)00408-5","volume":"10","author":"CR Steele","year":"2000","unstructured":"Steele CR, Oppenheim DE, Hayday AC (2000) \u03b3\u03b4 T cells: non\u2010classical ligands for non\u2010classical cells. Curr Biol 10: R282\u2013R285","journal-title":"Curr Biol"},{"key":"BFEMBR7401090_CR60","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1084\/jem.20031981","volume":"199","author":"SE Street","year":"2004","unstructured":"Street SE, Hayakawa Y, Zhan Y, Lew AM, MacGregor D, Jamieson AM, Diefenbach A, Yagita H, Godfrey DI, Smyth MJ (2004) Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and \u03b3\u03b4 T cells. J Exp Med 199: 879\u2013884","journal-title":"J Exp Med"},{"key":"BFEMBR7401090_CR61","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.it.2006.07.006","volume":"27","author":"LC Sullivan","year":"2006","unstructured":"Sullivan LC, Hoare HL, McCluskey J, Rossjohn J, Brooks AG (2006) A structural perspective on MHC class Ib molecules in adaptive immunity. Trends Immunol 27: 413\u2013420","journal-title":"Trends Immunol"},{"key":"BFEMBR7401090_CR62","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood-2005-11-011320","volume":"108","author":"CL Sutherland","year":"2006","unstructured":"Sutherland CL, Rabinovich B, Chalupny NJ, Brawand P, Miller R, Cosman D (2006) ULBPs, human ligands of the NKG2D receptor, stimulate tumour immunity with enhancement by IL\u201015. Blood 108: 1313\u20131319","journal-title":"Blood"},{"key":"BFEMBR7401090_CR63","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.0818-9641.2004.01254.x","volume":"82","author":"J Swann","year":"2004","unstructured":"Swann J, Crowe NY, Hayakawa Y, Godfrey DI, Smyth MJ (2004) Regulation of antitumour immunity by CD1d\u2010restricted NKT cells. Immunol Cell Biol 82: 323\u2013331","journal-title":"Immunol Cell Biol"},{"key":"BFEMBR7401090_CR64","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1073\/pnas.91.5.1883","volume":"91","author":"P Tabaczewski","year":"1994","unstructured":"Tabaczewski P, Shirwan H, Lewis K, Stroynowski I (1994) Alternative splicing of class Ib major histocompatibility complex transcripts in vivo leads to the expression of soluble Qa\u20102 molecules in murine blood. Proc Natl Acad Sci USA 91: 1883\u20131887","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR7401090_CR65","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.20022227","volume":"198","author":"M Terabe","year":"2003","unstructured":"Terabe M et al (2003) Transforming growth factor\u2010\u03b2 production and myeloid cells are an effector mechanism through which CD1d\u2010restricted T cells block cytotoxic T lymphocyte\u2010mediated tumour immunosurveillance: abrogation prevents tumour recurrence. J Exp Med 198: 1741\u20131752","journal-title":"J Exp Med"},{"key":"BFEMBR7401090_CR66","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.20051381","volume":"202","author":"M Terabe","year":"2005","unstructured":"Terabe M, Swann J, Ambrosino E, Sinha P, Takaku S, Hayakawa Y, Godfrey DI, Ostrand\u2010Rosenberg S, Smyth MJ, Berzofsky JA (2005) A nonclassical non\u2010V\u03b114J\u03b118 CD1d\u2010restricted (type II) NKT cell is sufficient for down\u2010regulation of tumour immunosurveillance. J Exp Med 202: 1627\u20131633","journal-title":"J Exp Med"},{"key":"BFEMBR7401090_CR67","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1600-065X.2006.00468.x","volume":"215","author":"A Thedrez","year":"2007","unstructured":"Thedrez A, Sabourin C, Gertner J, Devilder MC, Allain\u2010Maillet S, Fournie JJ, Scotet E, Bonneville M (2007) Self\/non\u2010self discrimination by human \u03b3\u03b4 T cells: simple solutions for a complex issue? Immunol Rev 215: 123\u2013135","journal-title":"Immunol Rev"},{"key":"BFEMBR7401090_CR68","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s002510100347","volume":"53","author":"T Ungchusri","year":"2001","unstructured":"Ungchusri T, Chiang EY, Brown G, Chen M, Tabaczewski P, Timares L, Stroynowski I (2001) Widespread expression of the nonclassical class I Qa\u20102 antigens in hemopoietic and nonhemopoietic cells. Immunogenetics 53: 455\u2013467","journal-title":"Immunogenetics"},{"key":"BFEMBR7401090_CR69","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.20030446","volume":"198","author":"DY Wu","year":"2003","unstructured":"Wu DY, Segal NH, Sidobre S, Kronenberg M, Chapman PB (2003) Cross\u2010presentation of disialoganglioside GD3 to natural killer T cells. J Exp Med 198: 173\u2013181","journal-title":"J Exp Med"},{"key":"BFEMBR7401090_CR70","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.4049\/jimmunol.169.3.1236","volume":"169","author":"J Wu","year":"2002","unstructured":"Wu J, Groh V, Spies T (2002) T cell antigen receptor engagement and specificity in the recognition of stress\u2010inducible MHC class I\u2010related chains by human epithelial \u03b3\u03b4 T cells. J Immunol 169: 1236\u20131240","journal-title":"J Immunol"},{"key":"BFEMBR7401090_CR71","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.20052271","volume":"203","author":"J Yan","year":"2006","unstructured":"Yan J, Parekh VV, Mendez\u2010Fernandez Y, Olivares\u2010Villagomez D, Dragovic S, Hill T, Roopenian DC, Joyce S, Van Kaer L (2006) In vivo role of ER\u2010associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. J Exp Med 203: 647\u2013659","journal-title":"J Exp Med"},{"key":"BFEMBR7401090_CR72","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/modpathol.3800751","volume":"20","author":"SR Ye","year":"2007","unstructured":"Ye SR, Yang H, Li K, Dong DD, Lin XM, Yie SM (2007) Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol 20: 375\u2013383","journal-title":"Mod Pathol"},{"key":"BFEMBR7401090_CR73","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1126\/science.1103440","volume":"306","author":"D Zhou","year":"2004","unstructured":"Zhou D et al (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786\u20131789","journal-title":"Science"},{"key":"BFEMBR7401090_CR74","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s00018-006-6341-y","volume":"63","author":"I Zidi","year":"2006","unstructured":"Zidi I, Guillard C, Marcou C, Krawice\u2010Radanne I, Sangrouber D, Rouas\u2010Freiss N, Carosella ED, Moreau P (2006) Increase in HLA\u2010G1 proteolytic shedding by tumour cells: a regulatory pathway controlled by NF\u2010\u03baB inducers. Cell Mol Life Sci 63: 2669\u20132681","journal-title":"Cell Mol Life Sci"}],"container-title":["The EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1038%2Fsj.embor.7401090","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/sj.embor.7401090.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1038\/sj.embor.7401090","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/sj.embor.7401090\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.1038\/sj.embor.7401090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/sj.embor.7401090.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T20:39:47Z","timestamp":1779136787000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/sj.embor.7401090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,1]]},"references-count":74,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11,1]]}},"alternative-id":["BFEMBR7401090"],"URL":"https:\/\/doi.org\/10.1038\/sj.embor.7401090","relation":{},"ISSN":["1469-221X","1469-3178"],"issn-type":[{"value":"1469-221X","type":"print"},{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,1]]},"assertion":[{"value":"30 January 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}